China Eye Valley is a national-level ophthalmic innovation ecosystem based in Wenzhou, China, integrating research, clinical care, industry, and investment. Anchored by the Wenzhou Medical University Eye Hospital, it supports the full pipeline from basic research to commercialization. The platform hosts over 400 eye health enterprises and offers advanced capabilities in biomaterials, medical devices, AI-driven diagnostics, and real-world evidence (RWE) studies. At ARVO, China Eye Valley showcases its collaborative model and seeks global partnerships to accelerate innovation, regulatory advancement, and market access in ophthalmology.
China Anti-Cancer Association
China Anti-Cancer Association (CACA) is a non-governmental and non-profit organization in the field of oncology in China. Founded in 1984, it has developed into the largest organization in cancer field with long history and great influence in China. Up to now, CACA has established local anti-cancer associations in all 31 provinces, cities, and autonomous regions across China, creating a network of 200 professional societies. With 162 organization members and over 800,000 individual members, CACA serves as a significant platform for academic exchanges, public education, promoting CACA Guidelines, and international cooperation in the field of oncology.
ChemPartner
Over the past twenty years, ChemPartner has evolved from a pure chemistry service provider to a research innovation engine with a broad portfolio of services spanning from discovery through development in both small molecule and large molecule therapeutics.
Charles River
Charles River is a global preclinical oncology CRO delivering end to end oncology and immuno oncology drug discovery, from target identification and validation through IND enabling and clinical. We partner with academic, biotechnology, and pharmaceutical companies to advance innovative cancer therapies. In 2025, Charles River supported 87% of FDA-approved oncology therapies, including first-in-class and best-in-class drugs. Our capabilities span small molecules, biologics, antibodies, antibody drug conjugates (ADCs), immunotherapies, checkpoint inhibitors, cell therapies, and gene therapies. Our research model (RMS) portfolio includes immunodeficient mice and rats, PBMC and CD34+ humanized mouse models, end-to-end support from colony management for Genetically Engineered Model (GEM), including transgenic model generation and breeding, to vivarium rental or customizable onsite services (staffing, consulting, training), and CRADL® support in global biohubs. Our oncology platforms include 1,700+ xenograft models (PDX, CDX, syngeneic, humanized), covering 45+ cancer indications across solid tumors, hematologic, and pediatric cancers. Integrated in vitro, ex vivo, NAMs and 3D tumor models—including organoids, tumoroids, and tissue microarrays (TMAs)- support efficacy, PK/PD, biomarker, and translational decision making. Multi omics, AI enabled analytics, and strategic CMC/CDMO capabilities help teams plan manufacturing earlier, strengthen regulatory readiness, improve study design, reduce risk, and accelerate candidate to patients. Learn more at criver.com/cancer-research-annual-meeting-2026 | Charles River has supported researchers in advancing ocular therapies for more than two decades, with a comprehensive suite of capabilities designed to meet your program needs. We help you progress small molecules, biologics, gene and cell therapies, and implantable devices from concept to clinic with confidence. Our team provides rigorous efficacy, distribution, and safety assessments supported by state-of-the-art imaging, functional evaluations, and New Approach Methodologies (NAMs) to help you improve predictability and generate high-quality data for global regulatory submissions. We also assess the ocular effects of systemic compounds for non-ocular indications, helping you refine study design, manage timelines and resources, and reduce animal use. We are committed to partnering with you at every stage to help bring meaningful treatments to patients worldwide because every moment matters. | Charles River provides essential products and services to support pharmaceutical and biotechnology companies, government agencies, and leading academic institutions worldwide in accelerating research and drug development. As a leader in scientific innovation, we are deeply committed to pioneering alternative methods that drive discovery while reducing reliance on traditional models. By embracing cutting-edge technologies and forward-thinking approaches, we enhance preclinical and clinical research. Our dedicated employees focus on delivering precisely what our clients need to improve, innovate, and expedite the discovery, early-stage development, and safe manufacture of new therapies for patients—because every moment matters. Learn more at www.criver.com. | Charles River is committed to helping companies like yours get your product to market safely and efficiently. Whether you’re still in development or already manufacturing, our Safety Assessment and Microbial Solutions services provide state-of-the-art technology and expert regulatory advice that will help you anticipate challenges, avoid roadblocks, and make better decisions.
CEVA Animal Health
Ceva Animal Health is a global veterinary health company specializing in the research, development, and production of pharmaceutical products and vaccines for companion animals, cattle, pigs, and poultry. In Canada, examples of products available for cattle production include PRID Delta, Zeleris, Eprecis, Ovarelin, Florkem, Cevaxel, and Enzaprost. Ceva is the leading French company in the animal health sector, with its headquarters located in Libourne, France. It is the world’s 5th largest animal health company, led by experienced veterinarians whose mission is to provide innovative health solutions for all animals, ensuring the highest standards of care and well-being. With over 7,000 employees across 47 countries, Ceva works every day to bring its One Health vision to life: “Together, beyond animal health.” Our 21 R&D centres and 33 production sites worldwide demonstrate our commitment to continuous research, innovation, and the development of solutions that meet the evolving needs of animals, veterinarians, and producers around the world. | Ceva Animal Health is a global leader in veterinary health, dedicated to enhancing the well-being of pets through innovative solutions. Our comprehensive portfolio of companion animal products is designed to support pet parents, veterinarians, and retailers in providing top-tier care for dogs and cats. ThunderWorks®: The Dog Calming Experts – Anxiety and stress can affect dogs in various situations, from thunderstorms and fireworks to travel and separation. ThunderWorks® provides pet-parent approved, veterinarian-recommended calming solutions, including the renowned ThunderShirt calming wrap, ThunderEase® pheromone diffusers and sprays, and ThunderWunders® calming chews, all formulated to help dogs feel safer and more secure. FELIWAY®: Happier Cats with Pheromone Support – Stress and anxiety are common issues for cats, leading to undesirable behaviors such as scratching, hiding, and urine marking. FELIWAY® pheromone products, including FELIWAY® Classic, FELIWAY® MultiCat, and FELIWAY® Optimum, mimic natural feline pheromones to create a calm and reassuring environment, helping cats feel at ease in their homes. Douxo® S3 & Douxo® Spa: Advanced Dermatology Solutions – Healthy skin is vital for pet comfort and well-being. Douxo® S3 offers scientifically formulated vet-recommended shampoos, mousses, and wipes to support pets with sensitive or problematic skin, while Douxo® Spa provides premium cleansing and nourishing solutions for routine pet grooming, ensuring a clean, hydrated, and well-maintained coat. Catego & Vectra: Powerful Flea & Tick Protection – Preventing parasites is key to keeping pets healthy. Catego® for cats and Vectra® for dogs and cats deliver fast-acting, long-lasting flea and tick protection, helping to safeguard pets from infestations and vector-borne diseases. At Ceva Animal Health, we are committed to providing innovative, vet-recommended solutions that enhance the lives of pets and their families. Visit booth #5422 to learn more about our trusted products and how they can benefit your customers! | Ceva Animal Health is a world-wide leader in the development and production of poultry vaccines to combat health issues such as Infectious Bursal Disease, Coccidiosis, Newcastle Disease, Marek’s Disease, Infectious Bronchitis Virus, and Salmonella. From the latest vector vaccine technology in the Vectormune range, to our custom made vaccines, we work together with our customers to find the right solution. To learn more visit www.ceva.us. | Ceva Animal Health is a global veterinary health company focused on the research, development, production and marketing of pharmaceutical products and vaccines for pets, livestock, swine and poultry.
CELLTREAT Scientific Products
CELLTREAT Scientific Products is a manufacturer of cell culture consumables and liquid handling instruments. CELLTREAT Scientific Products has a long-standing history of innovative design, developing an optimized user experience at an affordable price – the ultimate in ergonomics and productivity.
Celanese
Celanese’s VitalDose® drug delivery platform enables targeted ocular delivery of small molecules, biologics, and RNA for conditions like retinal disease, glaucoma, and inflammation. Offering both durable and degradable systems, the platform utilizes implants and inserts to ensure controlled drug release, reducing treatment burden while improving patient adherence and bioavailability. Partner with our Development & Feasibility Lab to overcome complex delivery challenges. Our experts are equipped to design and fabricate functional, drug-loaded prototypes, characterize morphology and release profiles, and provide seamless technical transfer support to meet your specific requirements. With decades of experience in medical and pharmaceutical applications, Celanese delivers world-class expertise and unrivaled service. We collaborate closely with you to refine development and elevate patient care through innovative, customized drug delivery solutions. | Celanese is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We are committed to sustainability by responsibly managing the materials we create for their entire lifecycle and are growing our portfolio of sustainable products to meet increasing customer and societal demand. We make a positive impact in our communities and prioritize diversity, equity and inclusion across our teams. Celanese is a Fortune 500 company that employs approximately 12,400 employees worldwide with 2023 net sales of $10.9 billion.
BullFrog AI
BullFrog AI is a technology-enabled drug discovery company using AI to aid in advancing the next generation of lifesaving medicine.
BTL Medical Technologies
Founded in 1993, BTL has grown to become one of the world’s major medical and aesthetic equipment manufacturers. With branches in over 80+ countries, BTL has revolutionized the way we offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments. BTL’s brands include EXION, EMFACE, EMSCULPT NEO, EMSCULPT, EMSELLA, and EMTONE. Please send all correspondence to info@btlnet.com. Additional information can be found at www.btlaesthetics.com/en_ca